Azimuth Capital Management’s Globus Medical GMED Stock Holding History

Azimuth Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$279K	Buy	3,785 +100	+3%	+$6.95K	0.01%	288
2021 Q4	$266K	Sell	3,685 -100	-3%	-$7.26K	0.01%	295
2021 Q3	$290K	Hold	3,785	–	–	0.01%	288
2021 Q2	$293K	Hold	3,785	–	–	0.01%	290
2021 Q1	$233K	Buy	3,785 +130	+4%	+$8.23K	0.01%	297
2020 Q4	$238K	Buy	+3,655	New	+$210K	0.01%	284
2020 Q1	–	Sell	-3,955	Closed	-$233K	–	267
2019 Q4	$233K	Hold	3,955	–	–	0.01%	269
2019 Q3	$202K	Buy	+3,955	New	+$188K	0.01%	274
2018 Q4	–	Sell	-4,110	Closed	-$233K	–	283
2018 Q3	$233K	Sell	4,110 -500	-11%	-$26.3K	0.02%	275
2018 Q2	$233K	Hold	4,610	–	–	0.02%	271
2018 Q1	$230K	Buy	+4,610	New	+$217K	0.02%	274

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Azimuth Capital Management's GMED Position: Q1 2022 in Review

Azimuth Capital Management increased its Globus Medical (GMED) stake by 2.7% in Q1 2022, buying an estimated $6.95K and bringing the position to 3,785 shares worth $279K. The position accounts for 0.01% of the portfolio, ranked #288.

Azimuth Capital Management first reported a position in GMED in Q1 2018 and has held it in 11 quarters since. The position peaked at $293K in Q2 2021. 377 funds tracked by Wall St. Rank hold GMED as of Q1 2022.

Azimuth Capital Management held 3,785 shares of Globus Medical worth $279K as of Q1 2022.
Azimuth Capital Management bought 100 Globus Medical shares in Q1 2022, an estimated $6.95K.
Globus Medical made up 0.01% of Azimuth Capital Management's portfolio in Q1 2022, its #288 holding.
Azimuth Capital Management first reported a position in Globus Medical in Q1 2018 and has held it in 11 quarters since.
Azimuth Capital Management's Globus Medical position peaked at $293K in Q2 2021.
377 funds tracked by Wall St. Rank held Globus Medical as of Q1 2022.

Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.